Product Information Update – Implanon NXT, 68 mg, implant for subdermal use (etonogestrel)

Notice type: 3rd Party Publications

Date: 01/05/2024

This update is to inform healthcare professionals of a recent update to the product information for Implanon NXT, 68mg implant for subdermal use (etonogestrel). This update relates to extending the use of Implanon NXT to allow insertion immediately postpartum (IPP) and immediately postabortion (IPA).

Please see the document linked below for further information.




Product name or type:
Implanon NXT, 68 mg, implant for subdermal use (etonogestrel) (PA 23198/017/001)


Authorisation Holder:

Organon Pharma (Ireland) Limited



Further Information:

Product Information Update – Implanon NXT 68mg, implant for subdermal use (etonogestrel) – 30 April 2024



« Back